This temporal regulation suggests distinct roles for these genes in GBM progression, with SOCS1 likely contributing to early-stage immune modulation and PHB2 supporting later-stage metabolic and survival adaptations in microglia. The gene discussed is SOCS1; the disease is glioblastoma.